Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-001265-17Phase 4Completed
Phase 4, open-label, single-arm trial of edoxaban in normal, sponsored by Turku University Hospital. Primary endpoints: Correlation between edoxaban peak plasma concentrations and ROTEM ExTEM values and Correlation between edoxaban peak plasma concentrations and ROTEM FibTEM values. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-001265-17.